Phibro Animal Health Corp
PAHC40.060USD
+0.190+0.48%
Cierre 01/15, 16:00（ET）Cotizaciones retrasadas 15 min
1.62BCap. mercado
23.94P/E TTM
Más Datos de Phibro Animal Health Corp Compañía
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Información de Phibro Animal Health Corp
Símbolo de cotizaciónPAHC
Nombre de la empresaPhibro Animal Health Corp
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoBendheim (Jack C)
Número de empleados2475
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 11
DirecciónGlenpointe Centre East, 3Rd Floor
CiudadTEANECK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07666
Teléfono12013297300
Sitio Webhttps://www.pahc.com/
Símbolo de cotizaciónPAHC
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoBendheim (Jack C)
Ejecutivos de Phibro Animal Health Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
202.35M
55.61%
Latin America and Canada
87.23M
23.97%
Europe & Middle East & Africa
44.94M
12.35%
Asia Pacific
29.38M
8.07%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Otro
67.35%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Otro
67.35%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
55.65%
Investment Advisor/Hedge Fund
29.60%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.19%
Sovereign Wealth Fund
0.05%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
421
20.39M
99.73%
-3.12M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
2.92M
14.28%
-23.05K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
1.52M
7.44%
-22.54K
-1.46%
Sep 30, 2025
State Street Investment Management (US)
894.04K
4.37%
-15.29K
-1.68%
Sep 30, 2025
Acadian Asset Management LLC
785.82K
3.84%
+61.38K
+8.47%
Sep 30, 2025
Renaissance Technologies LLC
555.20K
2.72%
-55.60K
-9.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
547.16K
2.68%
-7.77K
-1.40%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
485.51K
2.37%
-71.73K
-12.87%
Sep 30, 2025
Nuveen LLC
478.02K
2.34%
+19.45K
+4.24%
Sep 30, 2025
Fidelity Management & Research Company LLC
413.62K
2.02%
+354.02K
+594.03%
Sep 30, 2025
Castleknight Management LP
399.78K
1.96%
-131.56K
-24.76%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
Ver más
AAM Sawgrass US Small Cap Quality Growth ETF
Proporción2.49%
State Street SPDR S&P Pharmaceuticals ETF
Proporción1.19%
Innovator IBD 50 Fund ETF
Proporción1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción1.06%
Inspire Fidelis Multi Factor ETF
Proporción1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.02%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.76%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.61%
Invesco S&P SmallCap Health Care ETF
Proporción0.52%
Dividendos
Un total de
97.20M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
Ver más
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Phibro Animal Health Corp?
Los cinco principales accionistas de Phibro Animal Health Corp son:
BlackRock Institutional Trust Company, N.A. posee 2.92M acciones, lo que representa el 14.28% del total de acciones.
The Vanguard Group, Inc. posee 1.52M acciones, lo que representa el 7.44% del total de acciones.
State Street Investment Management (US) posee 894.04K acciones, lo que representa el 4.37% del total de acciones.
Acadian Asset Management LLC posee 785.82K acciones, lo que representa el 3.84% del total de acciones.
Renaissance Technologies LLC posee 555.20K acciones, lo que representa el 2.72% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 2.92M acciones, lo que representa el 14.28% del total de acciones.
The Vanguard Group, Inc. posee 1.52M acciones, lo que representa el 7.44% del total de acciones.
State Street Investment Management (US) posee 894.04K acciones, lo que representa el 4.37% del total de acciones.
Acadian Asset Management LLC posee 785.82K acciones, lo que representa el 3.84% del total de acciones.
Renaissance Technologies LLC posee 555.20K acciones, lo que representa el 2.72% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Phibro Animal Health Corp?
Los tres principales tipos de accionista de Phibro Animal Health Corp son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Phibro Animal Health Corp (PAHC)?
A fecha de 2025Q4, 421 instituciones poseen acciones de Phibro Animal Health Corp, con un valor de mercado combinado de aproximadamente 20.39M, lo que representa el 99.73% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -7.02%.
¿Cuál es la mayor fuente de ganancias de Phibro Animal Health Corp?
El FY2026Q1, el segmento empresarial MFAs and Other generó la ganancia más alta para Phibro Animal Health Corp, ascendiendo a 195.20M y representando el 53.64% de la ganancia total.
